Earplugs to reduce noise-related heart and metabolic risk
Official title: Impact of Personal Mitigation on Mechanisms Linking Transportation Noise Exposure to Cardiometabolic Disease
Run by Massachusetts General Hospital · NCT07148817 · Data updated 2026-11-12
This study will test whether wearing noise-canceling earplugs reduces stress-related brain activity and other heart-risk markers in adults with atherosclerosis or common cardiovascular risk factors who are bothered by transportation noise.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 26 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | October 15, 2025 |
| Main results expected | April 1, 2028 |
| Study ends | June 30, 2028 |
| Registry record updated | November 3, 2025 |
| Trial ID | NCT07148817 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults who are annoyed by transportation noise or live in areas with average residential noise greater than 45 dBA and who have stable atherosclerosis or at least one typical cardiovascular risk factor are the intended participants.
✕Probably not a fit
Patients already using personal noise mitigation or those excluded for safety or confounding reasons (for example recent stroke, certain cardiovascular medications, pregnancy, claustrophobia, or active severe psychiatric/substance use disorders) are unlikely to receive benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized interventional study compares nightly use of noise-canceling earplugs versus usual care in adults with stable atherosclerosis or at least one typical cardiovascular risk factor who report bothersome transportation noise or live in areas with high noise. Investigators will use FDG PET imaging to measure stress-associated neural activity (eg, amygdala-to-cortex metabolic patterns) and will collect autonomic, inflammatory, and vascular biomarkers before and after the intervention. Participants taking excluded cardiovascular medications or with neurologic/psychiatric contraindications will be screened out to ensure safety and interpretability. The goal is to determine whether simple personal noise mitigation lowers upstream stress signaling and downstream markers of cardiovascular risk.
Why it matters
Potential benefit: If successful, a low-cost intervention like earplugs could lower stress signaling and early markers of cardiovascular risk, potentially reducing long-term heart disease risk.
How similar studies have gone: Previous research has linked transportation noise to stress signaling and used FDG PET to measure stress-associated neural activity, but testing whether earplugs reduce those neural and cardiovascular markers is a relatively novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Describe feeling annoyed by transportation noise exposure or have high residential noise exposure (\>45 dBA average over 24 hours) using the United States Department of Transportation Map * Known stable atherosclerosis or at least one typical risk factor (i.e., hypertension, diabetes, active smoking, or hyperlipidemia) * Ability to understand and sign informed consent Exclusion Criteria: * History of stroke, brain surgery, or seizure * Use of certain CVD medications (e.g., beta-blockers, high-intensity statins \[e.g., rosuvastatin 20/40 mg and atorvastatin 40/80 mg\], PCSK-9 inhibitors) * Psychiatric or cardiovascular medication change within 3 months (i.e., stable regimen is allowed) * Unstable blood pressure or cardiac arrhythmia * Current use of personal noise mitigation techniques or involvement in stress management program * Moderate/severe alcohol/substance use disorder * Current mania/psychosis * Weight \>300 lbs. * Claustrophobia * Pregnancy * Metal implants * Uncontrolled hyperglycemia (HgbA1c\>7.5%) * Subjects who have had significant radiation exposure as part of research (\>2 nuclear tests, computed tomography images, or fluoroscopic procedures) during the preceding 12-months
Where it's running
-
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Michael Osborne, MD — Massachusetts General Hospital
- Study coordinator: Alula Assefa
- Email: aassefa2@mgh.harvard.edu
- Phone: 617-726-2393
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Differentiating heart disease in autoimmune vs. type 2 diabetes
This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.
-
Cardio-Metabolic Clinic care for adults with type 2 diabetes and cardiovascular disease
This trial tests whether a specialized Cardio-Metabolic Clinic can improve heart function and overall health for adults with type 2 diabetes and cardiovascular disease compared with usual care.
-
A safe test of a new medicine for healthy adults
This study tests a new medicine called NNC0705-0002 in healthy adults to see if it is safe and how it behaves in the body.
-
Nutrition Counselling for people with diabetes and high blood pressure
Aimed at adults with both type 2 diabetes and hypertension, this study tests whether structured nutrition counselling helps people stick to better diets and improve health-related quality of life.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Multilevel program to reduce noise exposure and protect hearing for farmworkers
A program with training and gear will be tested to see if it lowers workers' noise exposure and helps prevent hearing loss among farmworkers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.